R1 RCM (R1 RCM) Buyback Yield % : 0.26 (As of May. 23, 2024)

View and export this data going back to 2010. Start your Free Trial

What is R1 RCM Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

R1 RCM's current buyback yield was 0.26%.

R1 RCM Buyback Yield % Historical Data

The historical data trend for R1 RCM's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R1 RCM Buyback Yield % Chart

R1 RCM Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buyback Yield %

Get a 7-Day Free Trial

0.74

1.03

1.52

0.60

R1 RCM Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buyback Yield %	Get a 7-Day Free Trial															0.85	0.24	0.12	0.59	-

Competitive Comparison of R1 RCM's Buyback Yield %

For the Health Information Services subindustry, R1 RCM's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

R1 RCM's Buyback Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, R1 RCM's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where R1 RCM's Buyback Yield % falls into.

R1 RCM Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

R1 RCM's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-26.5	+	0)	/	4441.53514
	=	0.60%

R1 RCM's annualized Buyback Yield for the quarter that ended in Mar. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0)	*	4	/	5419.0024
	=	0.00%

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Mar. 2024) data.

R1 RCM Buyback Yield % Related Terms

Thank you for viewing the detailed overview of R1 RCM's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

R1 RCM (R1 RCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » R1 RCM Inc (NAS:RCM) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

6HL:Germany 6HL0:Germany

Address

434 West Ascension Way, 6th Floor, Murray, UT, USA, 84123

Website

https://www.r1rcm.com

R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.

Executives

Dominic Nakis	director	433 W ASCENSION WAY, SUITE 200, MURRAY UT 84123
Henneman John B Iii	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Evans Richard B. Jr.	officer: Principal Accounting Officer	C/O ACCRETIVE HEALTH, INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
John M. Sparby	officer: See Remarks	C/O R1 RCM INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Lee Rivas	officer: President	C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Kyle Hicok	officer: Chief Commercial Officer	434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Jennifer D. Williams	officer: Chief Financial Officer	434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Janie Wade	director	C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Tcp-asc Achi Series Lllp	director, 10 percent owner	65 E 55TH ST 27TH FLOOR, TOWERBROOK CAPITAL PARTNERS L.P., NEW YORK NY 10022
Joseph Gerard Flanagan	director, officer: Chief Executive Officer	C/O NORTEL NETWORKS CORPORATION, 195 THE WEST MALL, TORONTO A6 M9C 5K1
Brian K. Dean	director	R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Gary Steven Long	officer: See Remarks	7050 BRIXTON PLACE, SUWANEE GA 30024
Michael C. Feiner	director	1166 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK NY 10036
Matthew S. Holt	director	C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019
Bradford Kyle Armbrester	director	311 ARSENAL STREET, WATERTOWN MA 02472